Table 1. Markov model inputs: medical versus endoscopic versus surgical therapies for refractory GERD.
Probabilities | Estimates | Range (95 % CI) | Distribution | Supplemental references |
Survive TIF procedure | 0.999 | 0.990 to 1.000 | Beta | 1 |
Survive LNF procedure | 0.992 | 0.985 to 1.000 | Beta | 2–5 |
Initial success rate, TIF | 0.990 | 0.970 to 1.000 | Beta | 6 |
Initial success rate, LNF | 0.990 | 0.970 to 1.000 | Beta | 3, 7, 8 |
Adverse event rate, TIF | 0.020 | 0.010 to 0.030 | Beta | 6 |
Adverse event rate, LNF | 0.061 | 0.013 to 0.101 | Beta | 5, 9, 10 |
Immediate PPI discontinuation rate, TIF | 0.890 | 0.820 to 0.950 | Beta | 6 |
Immediate PPI discontinuation rate, LNF | 0.933 | 0.869 to 0.995 | Beta | 10, 11 |
1-year PPI discontinuation rate, TIF | 0.783 | 0.760 to 0.890 | Beta | 6, 12 |
1-year PPI discontinuation rate, LNF | 0.810 | 0.743 to 0.864 | Beta | 13, 14 |
2-year PPI discontinuation rate, TIF | 0.764 | 0.710 to 0.770 | Beta | 12, 15, 16 |
2-year PPI discontinuation rate, LNF | 0.760 | 0.706 to 0.805 | Beta | 17 |
3-year PPI discontinuation rate, TIF | 0.712 | 0.650 to 0.751 | Beta | 12, 16 |
3-year PPI discontinuation rate, LNF | 0.690 | 0.635 to 0.770 | Beta | 13, 18 |
5-year PPI discontinuation rate, TIF | 0.540 | 0.412 to 0.600 | Beta | 19, 20 |
5-year PPI discontinuation rate, LNF | 0.706 | 0.690 to 0.722 | Beta | 21 |
10-year PPI discontinuation rate, TIF | 0.417 | 0.330 to 0.510 | Beta | 20, 22 |
10-year PPI discontinuation rate, LNF | 0.589 | 0.570 to 0.608 | Beta | 21 |
Costs (US $, 2019) | ||||
|
$ 761.00 | $ 570.75 to $ 951.25 | Gamma | 23 |
|
$ 230.00 | $ 172.50 to $ 287.50 | Gamma | 23 |
|
$ 588.00 | $ 441.00 to $ 697.50 | Gamma | 23 |
|
$ 1.54 | $ 0.39 to $ 1.93 | Gamma | 24 |
|
$ 4.39 | $ 1.10 to $ 5.49 | Gamma | 24 |
|
$ 2410.51 | $ 2035.65 to $ 2785.38 | Gamma | 25 |
|
$ 7314.62 | $ 6950.25 to $ 9499.96 | Gamma | 25 |
|
$ 3078.45 | $ 2955.08 to $ 3201.82 | Gamma | 25 |
|
$ 10393.11 | $ 12429.99 to $ 13832.44 | Gamma | 25 |
|
$ 5177.00 | $ 3882.75 to $ 6471.25 | Gamma | 23, 26 |
Utilities (health states) | ||||
|
0.885 | 0.770 to 0.940 | Triangular | 3, 27, 28 |
|
0.998 | 0.980 to 1.000 | Triangular | 3, 29, 30 |
|
1.000 | – | – | – |
|
0.000 | – | – | – |
|
0.600 | 0.450 to 0.750 | Triangular | 3 |
|
0.500 | 0. 400 to 0.700 | Triangular | 3, 30 |
|
0.620 | 0. 550 to 0.800 | Triangular | 3, 30 |
|
0.620 | 0.500 to 0.750 | Triangular | 3, 30 |
GERD, gastroesophageal reflux disease; TIF, transoral incisionless fundoplication; LNF, laparoscopic Nissen fundoplication; CI, confidence interval; PPI, proton pump inhibitor.
Alternative PPI costs shown in Supplementary Material.